Current Studies

Click on a study for more information
Alzheimer's Disease (click here)

We are currently enrolling in studies for Alzheimer’s Disease.

Please contact Estela at 619-432-0867.

Simufilam 50 mg Or 100 mg For Mild-To-Moderate Alzheimer’s Disease (REFOCUS_ALZ).https://clinicaltrials.gov/ct2/show/NCT05026177

For more information, you can visit the patient website by clicking here

Assessment of safety and efficacy measured by amyloid reduction of remternetug in early symptomatic Alzheimer’s Disease. https://clinicaltrials.gov/ct2/show/NCT05463731?term=J1G-MC-LAKC&draw=2&rank=1

Please contact Estela at 619-432-0867.

Myasthenia Gravis (click here)

We are currently enrolling in studies for Myasthenia Gravis.

Please contact Lupe at 619-432-0954.

Descartes-08 CAR-T Cells In Generalized Myasthenia Gravis (MG).https://clinicaltrials.gov/ct2/show/NCT04146051

A Phase 3, Multi-center, Randomized, Quadruple‑blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants with Generalized Myasthenia Gravis (gMG).https://clinicaltrials.gov/ct2/show/NCT05403541?id=IMVT+1401-3101&draw=2&rank=1

FLEX Research Study for Adults with Generalized Myasthenia Gravis (gMG)

The FLEX study is a randomized, blinded, and placebo-controlled study assessing the efficacy and safety of an investigational drug for adults diagnosed with gMG. The injectable investigational drug is being evaluated over a 12-week induction period and a 12-week maintenance period. Based on completion of these periods and a participant’s response to the investigational drug, participation in a 52-week extension study of the investigational drug may be available to study participants. To learn more, please contact <<contact info>> www.gMG-research.com 

Multiple Sclerosis (click here)

We are currently enrolling in studies for Multiple Sclerosis.

Please contact Lupe at 619-432-0954.

A Study To Evaluate The Efficacy And Safety of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (Fenhance) .https://clinicaltrials.gov/ct2/show/NCT04586010

For more information, you can visit the patient website by clicking here.

Multiple Sclerosis (click here)

We are currently enrolling in studies for Multiple System Atrophy, Pure Autonomic Failure, and Lewy Body Dementia.

Please contact April at 619-432-0859

Synuclein-One Study .https://clinicaltrials.gov/ct2/show/NCT04700722

Current Areas of Research

Alzheimer's Disease/Dementia
Multiple Sclerosis (MS)
Myasthenia Gravis (MG)
Multiple System Atrophy
Pure Autonomic Failure
Lewy Body Dementia

Menu